Investig Clin Urol.
2022 Jul;63(4):369-372. 10.4111/icu.20220203.
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
- Affiliations
-
- 1Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea
- 2Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea
- 3Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea
- KMID: 2530905
- DOI: http://doi.org/10.4111/icu.20220203
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
- Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment
- BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis
- BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
- Cisplatin induces primary necrosis through poly(ADP-ribose) polymerase 1 activation in kidney proximal tubular cells
